Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Staging is the process of determining with specific tests whether cancer has spread and, if so, how far. It is important to know the stage of the disease in order to plan treatment and this also helps to predict outcome, or prognosis.
Stage I (1) Hodgkin's Lymphoma
Cancer is only in one group of lymph nodes, or it has started in one organ and has not moved to another part of the body.
Stage II (2) Hodgkin's Lymphoma
Cancer shown in two or more groups of lymph nodes and on the same side of the diaphragm in the body; all disease is in either the upper or lower half of the body. This means that if the lymph nodes in the neck and underarms both show cancer, it is stage II (2). However, if the lymph nodes in the groin and neck show cancer, it is not stage II (2), because those two parts of the body are on different sides of the diaphragm.
Cancer that is in one group of lymph nodes and extends directly into a nearby organ is also stage II (2).
Stage III (3) Hodgkin's Lymphoma
Cancer shown in two or more groups of lymph nodes on different sides of the diaphragm, such as the neck and groin. There might also be spread of the cancer from the lymph nodes to nearby organs.
Stage IV (4) Hodgkin's Lymphoma
Cancer has spread widely through distant organ(s) outside of the lymphatic system. Other lymph nodes in the body may or may not show signs of the cancer. Typical stage IV (4) disease is when Hodgkin's lymphoma is found in the bone marrow or in organs (lung, stomach, liver, bone).
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.